Imagine walking into your local pharmacy, ready to pick up a trusted supplement, only to discover it’s been pulled from the shelves due to a mysterious label alteration. This is exactly what happened with Seven Seas cod liver oil in Malta, leaving both consumers and retailers scratching their heads. But here’s where it gets controversial: the label “Not for EU” was crossed out on the outer packaging, yet it appeared clearly and unaltered on the inner container. What does this mean for the product’s legality and safety? Let’s dive in.
The issue came to light when pharmacies across Malta noticed the discrepancy on the Seven Seas cod liver oil packaging. One major pharmacy chain, Brown’s, took swift action by quarantining the affected batch as a precautionary measure. They’ve stated that the product will remain off the shelves until they receive formal confirmation from the supplier and manufacturer that the batch was approved for sale within the EU and that the label alteration was authorized. But this is the part most people miss: it’s still unclear whether other pharmacies stocking the same product have been informed or taken similar steps.
Neofarma, a wholesaler that has been importing Seven Seas products for 15 years, described the situation as a new and puzzling issue. They’ve reached out to the supplier for answers but remain unsure why the “Not for EU” label appeared on this particular batch. Interestingly, Seven Seas, a UK-based brand founded in 1935 and known for its nutritional supplements, is widely distributed in Malta, with nearly all pharmacies carrying their products. This raises questions about how such a discrepancy could occur in a well-established supply chain.
The Medicines Authority and the Malta Competition and Consumer Affairs Authority (MCCAA) have also been contacted for clarification, but responses are still pending. In the meantime, consumers are left wondering: Is this an isolated incident, or could it signal broader issues with product labeling and distribution? And here’s a thought-provoking question for you: Should pharmacies be more vigilant in checking product labels, or is this ultimately the responsibility of suppliers and regulators? Let us know your thoughts in the comments—this is a discussion worth having.
